🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Marker Therapeutics Inc (MRKR)

NASDAQ
Currency in USD
4.070
-0.650(-13.77%)
Closed
After Hours
4.060-0.010(-0.246%)
MRKR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
4.0004.680
52 wk Range
2.4386.157
Key Statistics
Edit
Prev. Close
4.72
Open
4.68
Day's Range
4-4.68
52 wk Range
2.438-6.157
Volume
87.89K
Average Volume (3m)
42.08K
1-Year Change
-19.72%
Book Value / Share
0.83
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MRKR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
19.000
Upside
+366.830%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Marker Therapeutics Inc Company Profile

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Compare MRKR to Peers and Sector

Metrics to compare
MRKR
Peers
Sector
Relationship
P/E Ratio
−3.8x−2.4x−0.6x
PEG Ratio
2.440.020.00
Price/Book
4.9x1.6x2.6x
Price / LTM Sales
6.7x9.4x3.2x
Upside (Analyst Target)
327.9%268.8%49.4%
Fair Value Upside
Unlock25.5%7.8%Unlock

Analysts' Recommendations

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 19.000

(+366.83% Upside)

FAQ

What Is the Marker Therapeutics (MRKR) Stock Price Today?

The Marker Therapeutics stock price today is 4.07

What Stock Exchange Does Marker Therapeutics Trade On?

Marker Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Marker Therapeutics?

The stock symbol for Marker Therapeutics is "MRKR."

What Is the Marker Therapeutics Market Cap?

As of today, Marker Therapeutics market cap is 35.87M.

What is Marker Therapeutics Earnings Per Share?

The Marker Therapeutics EPS is -1.09.

From a Technical Analysis Perspective, Is MRKR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.